Frontiers in Cellular and Infection Microbiology (Oct 2021)
Network of Interactions Between Gut Microbiome, Host Biomarkers, and Urine Metabolome in Carotid Atherosclerosis
- Rui-Jun Li,
- Rui-Jun Li,
- Zhu-Ye Jie,
- Zhu-Ye Jie,
- Zhu-Ye Jie,
- Qiang Feng,
- Qiang Feng,
- Qiang Feng,
- Qiang Feng,
- Qiang Feng,
- Rui-Ling Fang,
- Fei Li,
- Fei Li,
- Yuan Gao,
- Yuan Gao,
- Hui-Hua Xia,
- Hui-Hua Xia,
- Huan-Zi Zhong,
- Huan-Zi Zhong,
- Huan-Zi Zhong,
- Huan-Zi Zhong,
- Bin Tong,
- Bin Tong,
- Lise Madsen,
- Lise Madsen,
- Lise Madsen,
- Jia-Hao Zhang,
- Jia-Hao Zhang,
- Chun-Lei Liu,
- Zhen-Guo Xu,
- Jian Wang,
- Jian Wang,
- Huan-Ming Yang,
- Huan-Ming Yang,
- Xun Xu,
- Xun Xu,
- Yong Hou,
- Yong Hou,
- Susanne Brix,
- Karsten Kristiansen,
- Karsten Kristiansen,
- Karsten Kristiansen,
- Xin-Lei Yu,
- Xin-Lei Yu,
- Hui-Jue Jia,
- Hui-Jue Jia,
- Hui-Jue Jia,
- Hui-Jue Jia,
- Kun-Lun He,
- Kun-Lun He
Affiliations
- Rui-Jun Li
- Department of Geriatric Cardiology, the Second Medical Center & National Clinical Research Center for Geriatric Diseases, Chinese PLA General Hospital, Beijing, China
- Rui-Jun Li
- Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China
- Zhu-Ye Jie
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Zhu-Ye Jie
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Zhu-Ye Jie
- Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Qiang Feng
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Qiang Feng
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Qiang Feng
- Shenzhen Engineering Laboratory of Detection and Intervention of Human Intestinal Microbiome, Shenzhen, China
- Qiang Feng
- Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark
- Qiang Feng
- Department of Human Microbiome, School of Stomatology, Shandong University, Shandong Provincial Key Laboratory of Oral Tissue Regeneration, Jinan, China
- Rui-Ling Fang
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Fei Li
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Fei Li
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Yuan Gao
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Yuan Gao
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Hua Xia
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Hua Xia
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Huan-Zi Zhong
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Huan-Zi Zhong
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Huan-Zi Zhong
- Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Huan-Zi Zhong
- Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark
- Bin Tong
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Bin Tong
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Lise Madsen
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Lise Madsen
- Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark
- Lise Madsen
- Institute Marine Research (IMR), Bergen, Norway
- Jia-Hao Zhang
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Jia-Hao Zhang
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Chun-Lei Liu
- Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China
- Zhen-Guo Xu
- Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China
- Jian Wang
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Jian Wang
- 0James D. Watson Institute of Genome Sciences, Hangzhou, China
- Huan-Ming Yang
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Huan-Ming Yang
- 0James D. Watson Institute of Genome Sciences, Hangzhou, China
- Xun Xu
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Xun Xu
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Yong Hou
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Yong Hou
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Susanne Brix
- 1Department of Biotechnology and Biomedicine, Technical University of Denmark, Kongens Lyngby, Denmark
- Karsten Kristiansen
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Karsten Kristiansen
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Karsten Kristiansen
- Department of Biology, Laboratory of Genomics and Molecular Biomedicine, University of Copenhagen, Copenhagen, Denmark
- Xin-Lei Yu
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Xin-Lei Yu
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Jue Jia
- Department of Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Jue Jia
- China National GeneBank, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Jue Jia
- Shenzhen Key Laboratory of Human Commensal Microorganisms and Health Research, Beijing Genomics Institute (BGI)-Shenzhen, Shenzhen, China
- Hui-Jue Jia
- 2Macau University of Science and Technology, Macau, China
- Kun-Lun He
- Beijing Key Laboratory of Chronic Heart Failure Precision Medicine, Chinese PLA General Hospital, Beijing, China
- Kun-Lun He
- 3Analysis Center of Big Data, Medical Innovation Research Division, Chinese PLA General Hospital, Beijing, China
- DOI
- https://doi.org/10.3389/fcimb.2021.708088
- Journal volume & issue
-
Vol. 11
Abstract
Comprehensive analyses of multi-omics data may provide insights into interactions between different biological layers concerning distinct clinical features. We integrated data on the gut microbiota, blood parameters and urine metabolites of treatment-naive individuals presenting a wide range of metabolic disease phenotypes to delineate clinically meaningful associations. Trans-omics correlation networks revealed that candidate gut microbial biomarkers and urine metabolite feature were covaried with distinct clinical phenotypes. Integration of the gut microbiome, the urine metabolome and the phenome revealed that variations in one of these three systems correlated with changes in the other two. In a specific note about clinical parameters of liver function, we identified Eubacteriumeligens, Faecalibacteriumprausnitzii and Ruminococcuslactaris to be associated with a healthy liver function, whereas Clostridium bolteae, Tyzzerellanexills, Ruminococcusgnavus, Blautiahansenii, and Atopobiumparvulum were associated with blood biomarkers for liver diseases. Variations in these microbiota features paralleled changes in specific urine metabolites. Network modeling yielded two core clusters including one large gut microbe-urine metabolite close-knit cluster and one triangular cluster composed of a gut microbe-blood-urine network, demonstrating close inter-system crosstalk especially between the gut microbiome and the urine metabolome. Distinct clinical phenotypes are manifested in both the gut microbiome and the urine metabolome, and inter-domain connectivity takes the form of high-dimensional networks. Such networks may further our understanding of complex biological systems, and may provide a basis for identifying biomarkers for diseases. Deciphering the complexity of human physiology and disease requires a holistic and trans-omics approach integrating multi-layer data sets, including the gut microbiome and profiles of biological fluids. By studying the gut microbiome on carotid atherosclerosis, we identified microbial features associated with clinical parameters, and we observed that groups of urine metabolites correlated with groups of clinical parameters. Combining the three data sets, we revealed correlations of entities across the three systems, suggesting that physiological changes are reflected in each of the omics. Our findings provided insights into the interactive network between the gut microbiome, blood clinical parameters and the urine metabolome concerning physiological variations, and showed the promise of trans-omics study for biomarker discovery.
Keywords